On June 2, Astera Labs declined 3.06% overnight, trading at $310.48/share, with trading volume of approximately $66,000.

On the news front, the stock continues to face headwinds from Northland Capital Markets' recent downgrade from Outperform to Market Perform, citing elevated valuation and growing concerns that hyperscale cloud providers may cut AI infrastructure spending in 2027. According to FactSet data, the analyst consensus target price stands at $246.01, significantly below the current share price, highlighting considerable valuation pressure.

Additionally, the company's President and COO recently sold approximately 399,000 shares, while a trust associated with a former executive disclosed plans to sell an additional 30,000 shares. This insider selling activity has further reinforced market concerns about stretched valuations. Despite prior support from Anthropic's $100 billion compute agreement with AWS — which benefits Astera Labs as a key supplier of switching and signal conditioning products for Trainium chips — the persistent overhang from the downgrade and executive disposals has kept the stock under sustained pressure.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)